INVESTOR RELATIONS

Event Details

NantKwest at World Immunotherapy Congress

03/04/2019 - 03/05/2019

CONFERENCE DETAILS:

Date: Monday, March 4, 2019
Presentation Tile: NK-92®: a proven, versatile platform for target-specific NK cell immunotherapy
Presenter: Hans Klingemann, MD, PhD, Vice President, Research & Development
Time: 3:00 PM

Date: Tuesday, March 5, 2019
Presentation Tile: Commercial strategies in immunotherapy Panel Discussion
Presenter: David Pyrce, Senior Vice President, Innovation & Investor Relations
Time: 9:50 AM